Linked Life Data

9100160

Source:http://linkedlifedata.com/resource/pubmed/id/9100160

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-7-7
pubmed:abstractText
A commercial product, Libido (Libid, Libbido, Erosom and Ardorare, names used in different markets), which is based on components derived from fertilized, partly incubated chickens' eggs, has been used to treat diminished sexual desire in men. The results from two double-blind cross-over placebo-controlled experiments indicate that Libido has a significant enhancing effect on sexual desire in men with normal and reduced sexual drive. Over periods as short as 2 weeks, 58% of the participants with low sexual desire noticed improvement as assessed using a visual analogue scale. Data obtained from consumers suggest significant effects on the frequency of sexual intercourse, on increased self-esteem, on the level of happiness, and on stamina. In a separate Swedish study, 84% of 31 men reported increased sexual desire during 3 weeks on Libido. It takes 1-2 weeks of regular use of Libido (3 g twice daily) before noticeable changes are observed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-0605
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
62-70
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Sexual desire in men: effects of oral ingestion of a product derived from fertilized eggs.
pubmed:affiliation
Eskeland Electronics, Aas, Norway.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial